Fenofibrate as an anti-cancer treatment: an in vitro study on glioblastoma cells at various oxygen levels and on normal astrocytes
Abstract Fenofibrate, an active pharmaceutical ingredient (API) of the fibrate class approved by the U.S. Food and Drug Administration (FDA) for the treatment of hypercholesterolemia and hyperlipidemia, has emerged as a promising candidate for repurposing in cancer. Indeed, beyond its lipid-lowering...
Gardado en:
| Principais autores: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BMC
2026-05-01
|
| Series: | Cancer Cell International |
| Assuntos: | |
| Acceso en liña: | https://doi.org/10.1186/s12935-026-04309-z |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|